186 related articles for article (PubMed ID: 30537116)
1. HMGB1
Burbano C; Gómez-Puerta JA; Muñoz-Vahos C; Vanegas-García A; Rojas M; Vásquez G; Castaño D
Eur J Immunol; 2019 Feb; 49(2):323-335. PubMed ID: 30537116
[TBL] [Abstract][Full Text] [Related]
2. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
[TBL] [Abstract][Full Text] [Related]
3. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
Front Immunol; 2018; 9():322. PubMed ID: 29545790
[TBL] [Abstract][Full Text] [Related]
4. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
5. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus.
Lu J; Hu ZB; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ma KL
BMC Nephrol; 2019 Aug; 20(1):303. PubMed ID: 31382919
[TBL] [Abstract][Full Text] [Related]
6. Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.
Jog NR; Blanco I; Lee I; Putterman C; Caricchio R
Lupus; 2016 Dec; 25(14):1551-1557. PubMed ID: 27075010
[TBL] [Abstract][Full Text] [Related]
7. Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.
Mobarrez F; Vikerfors A; Gustafsson JT; Gunnarsson I; Zickert A; Larsson A; Pisetsky DS; Wallén H; Svenungsson E
Sci Rep; 2016 Oct; 6():36025. PubMed ID: 27777414
[TBL] [Abstract][Full Text] [Related]
8. High mobility group box protein 1 (HMGB1) serum and urinary levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus: A possible relation to lupus nephritis.
Hisham FA; Tharwat S; Samra NE; Mostafa N; Nassar MK; El-Desoky MM
Lupus; 2022 Dec; 31(14):1777-1785. PubMed ID: 36214106
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features.
Whittall-García LP; Torres-Ruiz J; Zentella-Dehesa A; Tapia-Rodríguez M; Alcocer-Varela J; Mendez-Huerta N; Gómez-Martín D
Lupus; 2019 Nov; 28(13):1549-1557. PubMed ID: 31619143
[TBL] [Abstract][Full Text] [Related]
10. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.
Abd-Elkareem MI; Al Tamimy HM; Khamis OA; Abdellatif SS; Hussein MR
Clin Exp Nephrol; 2010 Dec; 14(6):548-57. PubMed ID: 20714774
[TBL] [Abstract][Full Text] [Related]
11. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
Front Immunol; 2020; 11():256. PubMed ID: 32265898
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus.
Hossny E; El-Ghoneimy D; Soliman DA; Ashour A
Int J Rheum Dis; 2019 Aug; 22(8):1402-1409. PubMed ID: 30938057
[TBL] [Abstract][Full Text] [Related]
13. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suárez A
Int J Cardiol; 2017 Jun; 236():138-144. PubMed ID: 28279502
[TBL] [Abstract][Full Text] [Related]
14. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
[TBL] [Abstract][Full Text] [Related]
15. Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis.
Atehortúa L; Rojas M; Vásquez G; Muñoz-Vahos CH; Vanegas-García A; Posada-Duque RA; Castaño D
Arthritis Res Ther; 2019 Jan; 21(1):34. PubMed ID: 30674349
[TBL] [Abstract][Full Text] [Related]
16. Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis.
Zickert A; Palmblad K; Sundelin B; Chavan S; Tracey KJ; Bruchfeld A; Gunnarsson I
Arthritis Res Ther; 2012 Feb; 14(1):R36. PubMed ID: 22348591
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus.
Li Y; Lee PY; Sobel ES; Narain S; Satoh M; Segal MS; Reeves WH; Richards HB
Arthritis Res Ther; 2009; 11(1):R6. PubMed ID: 19144150
[TBL] [Abstract][Full Text] [Related]
18. [Urinary soluble intercellular adhesion molecule-1 and vascular cellular adhesion molecule-1: potential biomarkers of active lupus nephritis].
Wu C; Yang M; Zhou Z; Feng X; Zhong X; Cui S; Wu L; Cao W
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1272-6, 1282. PubMed ID: 26403737
[TBL] [Abstract][Full Text] [Related]
19. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
20. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
